Hidenori Maruyama, MSc

Hidenori Maruyama, MSc is affiliated with Medical Science, Sumitomo Pharma Co., Ltd., Tokyo, Japan. Hidenori Maruyama has contributed 1 peer-reviewed article published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2024. Their work focuses on Schizophrenia/Schizoaffective Disorders.

Schizophrenia/Schizoaffective Disorders

Frequent co-authors

Fumiya Sano Itaru Miura Keisuke Okamoto Reiko Sakaguchi
JCP
Effect of Lurasidone on Social Functioning
Original Research

January 31, 2024

Impaired social functioning in schizophrenia affects personal recovery. This analysis looked at the effects of lurasidone on social functioning in schizophrenia during a double-blind, placebo-controlled study and subsequent open-label...
, , , et al

Live Webinar
and Q&A With
Dr Deligiannidis

JULY 16 · REGISTER NOW
Webinar ad featuring Dr. Kristina M. Deligiannidis on PPD treatment options

Subscribe to read
more articles

Subscribe